Literature DB >> 5292718

Clinical experience with L-asparaginase.

H F Oettgen, L Tallal, C C Tan, M L Murphy, B D Clarkson, R D Golbey, I H Krakoff, D A Karnofsky, H J Burchenal.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1970        PMID： 5292718     DOI： 10.1007/978-3-642-99984-0_27

Source DB:  PubMed          Journal:  Recent Results Cancer Res        ISSN： 0080-0015


× No keyword cloud information.
  5 in total

1.  Purification and Some Biological Properties of Asparaginase from Azotobacter vinelandii.

Authors:  S A Gaffar; Y I Shethna
Journal:  Appl Environ Microbiol       Date:  1977-03       Impact factor: 4.792

2.  Myelosuppressive effect of colaspase (L-asparaginase) in initial treatment of acute lymphoblastic leukaemia.

Authors:  P G Johnston; R M Hardisty; H E Kay; P G Smith
Journal:  Br Med J       Date:  1974-07-13

Review 3.  Cell-penetrating peptides meditated encapsulation of protein therapeutics into intact red blood cells and its application.

Authors:  Huining He; Junxiao Ye; Yinsong Wang; Quan Liu; Hee Sun Chung; Young Min Kwon; Meong Cheol Shin; Kyuri Lee; Victor C Yang
Journal:  J Control Release       Date:  2013-12-27       Impact factor: 9.776

4.  Hepatomegaly and fever at the time of neutrophil recovery revealing L-asparaginase toxicity in the treatment of acute lymphoblastic leukemia.

Authors:  Julien Saison; Françoise Berger; Fanny Lebosse; Regis Audoual; Xavier Thomas; Mauricette Michallet
Journal:  Am J Case Rep       Date:  2014-01-12

Review 5.  Detailed Molecular Mechanisms Involved in Drug-Induced Non-Alcoholic Fatty Liver Disease and Non-Alcoholic Steatohepatitis: An Update.

Authors:  Laura Giuseppina Di Pasqua; Marta Cagna; Clarissa Berardo; Mariapia Vairetti; Andrea Ferrigno
Journal:  Biomedicines       Date:  2022-01-17
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.